Mersana Therapeutics, Inc. MRSN
29.08 USD +29.08
Day range unavailable
52-week range unavailable
- YTD
- +0.52%
- 1 year
- -14.47%
Latest period ending Dec 31, 2024 · select a line to chart its full history
Annual cash flow
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 4.74M | 4.30M | 3.70M | 2.68M | 1.01M | |
| 4.09M | 94.67M | 153.02M | 63.65M | 230.41M | |
| -66.81M | 45.68M | -49.06M | -76.99M | 192.74M | |
| -132.00K | -2.17M | -2.20M | -648.00K | -473.00K | |
| 6.32M | 95.09M | 153.29M | 45.56M | 230.72M | |
| -2.23M | -412.00K | -272.00K | 18.34M | -313.00K | |
| 11.44M | 119.88M | -152.72M | -648.00K | 37.03M | |
| 11.57M | 122.05M | -150.52M | 0 | 37.50M | |
| -82.34M | -168.88M | -49.36M | -139.99M | -74.70M | |
| 16.46M | 21.14M | 21.52M | 18.41M | 7.17M |
